Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Qualcomm (NASDAQ:QCOM) Fiscal 2026 Earnings: Revenue USD 43.12B

The company describes its platforms as spanning handsets, automotive, IoT and data center, built on Snapdragon, Dragonwing and Dragonfly products.Research and Developmentexpense was USD 10.21 billion against USD 9.04 billion, and the company citedInvestmentin theData Centerbusiness, higher employee costs and lower engineering cost reimbursements.

Nitish Kishor | 05 November 2026

What Drove Root (NASDAQ:ROOT) Net Combined Ratio to 97.2% in Q3?

Management said the direct channel is tuned to bid for high-intent shoppers while balancing competitive prices against target unit economics, while the partnership channel gives access to customers inside partner experiences. Gross premiums written were USD 357.5 million against USD 387.2 million, which the …

Nitish Kishor | 05 November 2026

QuinStreet (NASDAQ:QNST) Fiscal Q1 2027 Earnings: Revenue USD 416.7M

Financial Services revenue was USD 270.96 million, against USD 207.48 million a year earlier. Chief executive Doug Valenti said carrierDemandin auto insurance continued and broadened, and that the company made progress widening its footprint with those clients.

Nitish Kishor | 05 November 2026

Ridgepost Capital (NYSE:RPC) Q3 Results Show Fee-Paying AUM of USD 35.2B

Fee-related revenue was stated as 17% higher than a year earlier. Fee-related earnings were USD 43.0 million, up 19%, with a fee-related earningsMarginof 48%. Adjusted net income was USD 32.3 million, a 13% increase.

Nitish Kishor | 05 November 2026

Q32 Bio (NASDAQ:QTTB) Q3 Earnings: Net Loss USD 0.26 per Share

The company has not generated revenue from product sales since inception and reported none in the quarter. It recognized collaboration arrangement revenue in earlier years under agreements tied to Horizon Therapeutics, which were later terminated and amended. In November 2025 the company sold substantially …

Nitish Kishor | 05 November 2026

Rapid7 (NASDAQ:RPD) Reports Q3 Results With 12% Workforce Reduction Underway

The company described the plan as designed to simplify operations and align resources with its core platform. Restructuring charges were USD 9.99 million in the quarter and USD 11.66 million for the nine months.

Nitish Kishor | 05 November 2026

Rapport Therapeutics (NASDAQ:RAPP) Q3 Earnings: Cash USD 395.0M

The October 2026 offerings included 9,761,905 shares at USD 21.00 and pre-funded warrants for up to 1,190,476 shares, with net proceeds of approximately USD 215.7 million. A separate offering of USD 172.5 million of 2.25% convertible senior notes due December 1, 2032 had net …

Nitish Kishor | 05 November 2026

Sunrun (NASDAQ:RUN) Q3 Earnings: Total Revenue Reported at USD 1.10B

Customer agreements and incentives revenue was USD 553.5 million, up 13%, with the company citing new systems placed in service and a full quarter of revenue from systems placed in service in the third quarter of 2025. Energy systems and product sales revenue was …

Nitish Kishor | 05 November 2026

Arcus Biosciences (NYSE:RCUS) Q3 Earnings: Net Loss of USD 128M

Total revenue was USD 9 million, compared with USD 26 million in the third quarter of 2025 and an estimate of USD 7.58 million. License and development services revenue was USD 8 million against USD 20 million a year earlier, and other collaboration revenue …

Nitish Kishor | 05 November 2026

Revolution Medicines (NASDAQ:RVMD) Q3 Earnings: FDA Approves RASONQUE

Management said third quarterRevenuereflects both patientDemandand initial stocking in the distribution channel, and is not necessarily indicative of underlying demand or future periods. In October 2026 the CHMP adopted a positive opinion recommending EUMarketingauthorization, which the European Commission reviews next.

Nitish Kishor | 05 November 2026
Support

Hi! How can we help you today?

Loading…